Author
The author works as a Correspondent with BW Businessworld
Gland Pharma on Thursday announced its earnings for the fourth quarter and full year FY23. The company's revenue recorded a slump in Q4FY23 by 29.4 per cent year on year (YoY) to be recorded at Rs 824 crore and by 16.6 per cent for FY23 to Rs 3,856 crore compared with Rs 1,168 crore in Q4FY22 and Rs 4,624 in FY22 respectively
Read More
Zydus Lifesciences on Thursday announced its earnings for the fourth quarter and full year FY23. The company's consolidated revenue recorded a major jump in Q4FY23 by 31.7 per cent year on year (YoY) to Rs 5,010 crore and by 14.1 per cent for FY23 to Rs 17,237 crore compared with Rs 3,805 crores in Q4FY22 and Rs 15,109 in FY22 respectively
Read More
Max Healthcare, the Indian healthcare provider headquartered in New Delhi has reported its earnings for the quarter that ended on 31st March 2023, the hospital chain has registered a rise of 26 per cent year on year in its consolidated revenue to be recorded at Rs 1,637 crores in the Quarter Four of Financial Year 2023(Q4FY23) up from Rs 1,296 crores in the corresponding quarter last year
Read More
On the rising medical inflation in India which reports say is approximately at 14 per cent presently and is also the highest in Southeast Asia, Dr Sangita Reddy, Joint MD, Apollo Hospitals said while defending the Indian healthcare costs that the high-quality healthcare in India is available at one-tenth or one-sixth of the global prices and its prices are not high in many areas
Read More
Cipla Limited, the Indian pharmaceutical major headquartered in Mumbai has reported its earnings for the quarter that ended on 31st March 2023, the Indian pharma giant has registered a rise of 8.3 per cent in its consolidated revenue to be recorded at Rs 5,739 crores in the Quarter Four of Financial Year 2022(Q4FY23) up from Rs 5,260 crores in the corresponding quarter last year
Read More
In an exclusive conversation with BW Healthcare World, Dr Raajiv Singhal, Managing Director and Group CEO, Marengo Asia Hospitals speaks on the possible acquisition options, rising consolidation & price concern, the growth & challenges of the healthcare industry, and future plans of the hospital chain
Read More
The healthtech industry in India is gearing up for exciting times ahead, say industry pundits and several reports as the sector is growing rapidly and exponentially. According to a 2022 report by consulting firm RedSeer, post-pandemic the healthtech sector is set to grow at a CAGR of 35 to 45 per cent over the next five to ten years
Read More
In an exclusive conversation with BW Healthcare World, Dr Ashok Seth, Chairman, Fortis Escorts Heart Institute stated that in India, Coronary Artery Disease (CAD) is on the rise adding that while the West has managed to curb deaths from coronary disease its numbers are going up in India
Read More
IOL Chemicals and Pharmaceuticals, a manufacturer of pharmaceutical APIs and speciality chemicals, announced its financial results for the fourth quarter and fiscal year that ended March 31, 2023 on Friday, the company registered a 2.9 per cent rise in its consolidated revenues year on year
Read More
The six strategies of the National Medical Device Policy 2023, propose to augment the growth story of the medical devices industry in India and entail focus areas such as streamlining regulation, enabling infrastructure, facilitating R&D and innovation, inviting investments, facilitating skilled manpower and promoting the industry for exports
Read More
